U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.2050G>A (p.Ala684Thr) AND Familial hypercholesterolemia

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Jan 8, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001057854.14

Allele description [Variation Report for NM_000527.5(LDLR):c.2050G>A (p.Ala684Thr)]

NM_000527.5(LDLR):c.2050G>A (p.Ala684Thr)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.2050G>A (p.Ala684Thr)
HGVS:
  • NC_000019.10:g.11120432G>A
  • NG_009060.1:g.36052G>A
  • NM_000527.5:c.2050G>AMANE SELECT
  • NM_001195798.2:c.2050G>A
  • NM_001195799.2:c.1927G>A
  • NM_001195800.2:c.1546G>A
  • NM_001195803.2:c.1606+199G>A
  • NP_000518.1:p.Ala684Thr
  • NP_000518.1:p.Ala684Thr
  • NP_001182727.1:p.Ala684Thr
  • NP_001182728.1:p.Ala643Thr
  • NP_001182729.1:p.Ala516Thr
  • LRG_274t1:c.2050G>A
  • LRG_274:g.36052G>A
  • LRG_274p1:p.Ala684Thr
  • NC_000019.9:g.11231108G>A
  • NM_000527.4:c.2050G>A
  • c.2050G>A
Protein change:
A516T
Links:
LDLR-LOVD, British Heart Foundation: LDLR_000754; dbSNP: rs774730452
NCBI 1000 Genomes Browser:
rs774730452
Molecular consequence:
  • NM_001195803.2:c.1606+199G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000527.5:c.2050G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.2050G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.1927G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.1546G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial hypercholesterolemia
Identifiers:
MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001222369Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Jan 8, 2024)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV001347392Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 22, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV002086861Natera, Inc.
no assertion criteria provided
Uncertain significance
(Feb 10, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Low-density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia.

Khoo KL, van Acker P, Defesche JC, Tan H, van de Kerkhof L, Heijnen-van Eijk SJ, Kastelein JJ, Deslypere JP.

Clin Genet. 2000 Aug;58(2):98-105.

PubMed [citation]
PMID:
11005141
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001222369.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 684 of the LDLR protein (p.Ala684Thr). This variant is present in population databases (rs774730452, gnomAD 0.02%). This missense change has been observed in individuals with hypercholesterolemia (PMID: 11005141; Invitae). This variant is also known as A663T. ClinVar contains an entry for this variant (Variation ID: 252192). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LDLR protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV001347392.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This missense variant (also known as p.Ala663Thr in the mature protein) replaces alanine with threonine at codon 684 of the LDLR protein. Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with familial hypercholesterolemia (PMID: 11005141, 26608663). This variant has been identified in 4/251258 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002086861.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024